4.7 Article

Tracking Monocyte Recruitment and Macrophage Accumulation in Atherosclerotic Plaque Progression Using a Novel hCD68GFP/ApoE-/- Reporter Mouse-Brief Report

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.116.308367

关键词

atherosclerosis; GFP; macrophage; model; monocyte; mouse; trafficking

资金

  1. British Heart Foundation [RG/15/10/31485, RG/12/5/29576, FS/12/69/30008]
  2. Wellcome Trust [090532/Z/09/Z]
  3. National Institute for Health Research (NIHR) Oxford Biomedical Research Centre
  4. BHF Centre of Research Excellence, Oxford [RE/13/1/30181]
  5. British Heart Foundation [RG/07/003/23133, PG/15/35/31403, RG/15/10/31485, RG/12/5/29576, RG/17/10/32859] Funding Source: researchfish
  6. Novo Nordisk Fonden [NNF15SA0018346, NNF15SA0018486] Funding Source: researchfish

向作者/读者索取更多资源

Objective-To create a model of atherosclerosis using green fluorescent protein (GFP)-targeted monocytes/macrophages, allowing analysis of both endogenous GFP(+) and adoptively transferred GFP(+) myeloid cells in arterial inflammation. Approach and Results-hCD68GFP reporter mice were crossed with ApoE(-/-) mice. Expression of GFP was localized to macrophages in atherosclerotic plaques and in angiotensin II-induced aortic aneurysms and correlated with galectin 3 and mCD68 expression. Flow cytometry confirmed GFP(+) expression in CD11b(+)/CD64(+), CD11c(+)/MHC-IIHI, and CD11b(+)/F4/80(+) myeloid cells. Adoptive transfer of GFP(+) monocytes demonstrated monocyte recruitment to both adventitia and atherosclerotic plaque, throughout the aortic root, within 72 hours. We demonstrated the biological utility of hCD68GFP monocytes by comparing the recruitment of wild-type and CCR2(-/-) monocytes to sites of inflammation. Conclusions-hCD68GFP/ApoE(-/-) mice provide a new approach to study macrophage accumulation in atherosclerotic plaque progression and to identify cells recruited from adoptively transferred monocytes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据